NRx Pharmaceuticals (NRXP) Competitors $1.57 +0.15 (+10.56%) (As of 05:19 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NRXP vs. AADI, KRON, SPRO, IVVD, IMRX, IMMX, ALTS, STTK, ALVR, and IOBTShould you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include Aadi Bioscience (AADI), Kronos Bio (KRON), Spero Therapeutics (SPRO), Invivyd (IVVD), Immuneering (IMRX), Immix Biopharma (IMMX), Janone (ALTS), Shattuck Labs (STTK), AlloVir (ALVR), and IO Biotech (IOBT). These companies are all part of the "pharmaceutical products" industry. NRx Pharmaceuticals vs. Aadi Bioscience Kronos Bio Spero Therapeutics Invivyd Immuneering Immix Biopharma Janone Shattuck Labs AlloVir IO Biotech Aadi Bioscience (NASDAQ:AADI) and NRx Pharmaceuticals (NASDAQ:NRXP) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability. Do insiders & institutionals have more ownership in AADI or NRXP? 52.1% of Aadi Bioscience shares are held by institutional investors. Comparatively, 4.3% of NRx Pharmaceuticals shares are held by institutional investors. 37.3% of Aadi Bioscience shares are held by company insiders. Comparatively, 19.0% of NRx Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger valuation & earnings, AADI or NRXP? NRx Pharmaceuticals has lower revenue, but higher earnings than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than NRx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAadi Bioscience$25.07M2.95-$65.76M-$2.28-1.32NRx PharmaceuticalsN/AN/A-$30.15M-$2.14-0.73 Do analysts rate AADI or NRXP? Aadi Bioscience currently has a consensus target price of $1.67, indicating a potential downside of 44.44%. NRx Pharmaceuticals has a consensus target price of $32.00, indicating a potential upside of 1,938.22%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe NRx Pharmaceuticals is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00NRx Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is AADI or NRXP more profitable? NRx Pharmaceuticals has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. NRx Pharmaceuticals' return on equity of 0.00% beat Aadi Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Aadi Bioscience-246.06% -71.87% -57.28% NRx Pharmaceuticals N/A N/A -449.16% Which has more risk and volatility, AADI or NRXP? Aadi Bioscience has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, NRx Pharmaceuticals has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Does the MarketBeat Community believe in AADI or NRXP? NRx Pharmaceuticals received 2 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 100.00% of users gave NRx Pharmaceuticals an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote. CompanyUnderperformOutperformAadi BioscienceOutperform Votes1139.29% Underperform Votes1760.71% NRx PharmaceuticalsOutperform Votes13100.00% Underperform VotesNo Votes Does the media refer more to AADI or NRXP? In the previous week, Aadi Bioscience had 5 more articles in the media than NRx Pharmaceuticals. MarketBeat recorded 7 mentions for Aadi Bioscience and 2 mentions for NRx Pharmaceuticals. NRx Pharmaceuticals' average media sentiment score of 1.31 beat Aadi Bioscience's score of 0.19 indicating that NRx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aadi Bioscience 0 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NRx Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryNRx Pharmaceuticals beats Aadi Bioscience on 13 of the 18 factors compared between the two stocks. Ad InvestorPlaceWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXP vs. The Competition Export to ExcelMetricNRx PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.99M$6.71B$5.22B$9.27BDividend YieldN/A3.00%5.12%4.29%P/E Ratio-0.7310.5887.4217.27Price / SalesN/A195.781,166.39119.60Price / CashN/A57.1543.2337.83Price / Book-1.145.164.834.93Net Income-$30.15M$151.58M$120.46M$225.34M7 Day Performance-4.27%-0.64%-0.26%1.13%1 Month Performance24.60%-3.02%15.99%2.76%1 Year Performance-96.53%8.81%30.22%16.90% NRx Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXPNRx Pharmaceuticals3.4683 of 5 stars$1.57+10.6%$32.00+1,938.2%-96.9%$18.99MN/A-0.732News CoveragePositive NewsGap UpHigh Trading VolumeAADIAadi Bioscience1.8289 of 5 stars$2.36-2.1%$1.67-29.4%+45.2%$58.17M$25.07M-1.0640News CoveragePositive NewsKRONKronos Bio3.4015 of 5 stars$0.95-3.0%$1.63+71.0%-25.8%$57.35M$9.86M-0.69100SPROSpero Therapeutics4.5795 of 5 stars$1.05-2.3%$5.00+378.5%-31.9%$56.97M$103.78M15.2946News CoverageIVVDInvivyd3.7327 of 5 stars$0.45-17.6%$7.89+1,650.8%-87.9%$53.89M$11.56M-0.28100Positive NewsGap UpIMRXImmuneering3.0171 of 5 stars$1.74+6.1%$12.80+637.8%-68.6%$53.87M$320,000.00-0.8360IMMXImmix Biopharma2.9238 of 5 stars$1.95-4.4%$7.00+259.0%-69.7%$53.64MN/A-2.479ALTSJanoneN/A$3.80-3.1%N/AN/A$53.46M$7.11M0.00170Gap UpSTTKShattuck Labs2.7353 of 5 stars$1.10-3.9%$8.67+691.5%-83.3%$52.28M$1.66M-0.75100ALVRAlloVir1.2552 of 5 stars$0.45+0.4%N/A-41.2%$52.24MN/A-0.51110IOBTIO Biotech3.7352 of 5 stars$0.79-2.8%$9.33+1,085.0%-40.7%$51.89MN/A-0.5930News Coverage Related Companies and Tools Related Companies Aadi Bioscience Alternatives Kronos Bio Alternatives Spero Therapeutics Alternatives Invivyd Alternatives Immuneering Alternatives Immix Biopharma Alternatives Janone Alternatives Shattuck Labs Alternatives AlloVir Alternatives IO Biotech Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRXP) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXP Stock Alerts